Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
26.00
+0.07 (0.27%)
May 7, 2026, 3:37 PM EDT - Market open

Ultragenyx Pharmaceutical Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
369.31M339.18M321.49M314.47M285.47M265.30M230.30M198.70M
Product Growth
29.37%27.85%39.59%58.26%58.24%68.34%55.82%45.67%
Other
303.42M291.43M288.69M276.21M274.71M257.40M250.90M243.80M
Other Growth
10.45%13.22%15.06%13.29%8.24%1.90%2.37%2.65%

Revenue by Geography

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
North America
361.22M354.58M340.56M340.46M316.40M307.30M297.70M307.10M
North America Growth
14.16%15.39%14.40%10.86%5.82%3.05%4.02%9.29%
Latin America
149.83M144.47M150.40M130.71M130.30M109.50M89.70M77.30M
Latin America Growth
14.99%31.93%67.67%69.10%93.32%70.30%55.46%72.93%
Europe
103.33M97.65M87.45M80.12M69.60M60.40M54.20M47.60M
Europe Growth
48.47%61.68%61.35%68.33%63.00%58.53%44.15%30.77%
Japan
12.64M9.79M8.69M5.40M6.40M4.10M1.00M2.20M
Japan Growth
97.48%138.66%768.50%145.45%433.33%70.83%-58.33%83.33%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.